Anglopharma
ActiveSummary
Anglopharma has been active since 1968 and the Belgian State Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €504k and a net result of €16k. Equity remains stable across the filed fiscal years (±2.5% per year). Its solvency ranks better than 85% of 220 sector peers (fiscal year 2026). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2026
82
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2025
Profitability57▲+54
Solvency100=
Growth78▲+26
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity ample (current ratio 3.45 against 4.05 in 2025; short-term debt: 24.4% and cash: 33.4% of total assets), and 24.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2026Solvency, return and age of the figures
Solvency
75.3%
Return on assets
2.3%
Age of the figures
8 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-01-2026 was due by 31-08-2026 and was filed on 03-06-2026, 89 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2026
89 d early
2025
22 d late
2024
25 d late
2023
29 d late
2022
22 d late
2021
28 d late
2020
60 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-01-2027 and is due by 31-08-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-01-2027 close31-08-2027 deadline
Financials · fiscal year 2026, abbreviated schema
Equity
€504k▼ 1.3%
2025 · €511k
2019: €438k
2020: €449k
2021: €460k
2022: €490k
2023: €528k
2024: €594k
2025: €511k
2019 → 2026
Total assets
€670k▲ 4.0%
2025 · €644k
2019: €811k
2020: €755k
2021: €792k
2022: €727k
2023: €738k
2024: €742k
2025: €644k
2019 → 2026
Net result
€16k
2025 · €-83k
2019: €6k
2020: €11k
2021: €11k
2022: €30k
2023: €38k
2024: €66k
2025: €-83k
2019 → 2026
Working capital
€400k▼ 1.4%
2025 · €406k
2019: €434k
2020: €408k
2021: €380k
2022: €372k
2023: €419k
2024: €481k
2025: €406k
2019 → 2026
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20222023202420252026Trend
Equity€490k-€528k▲ 7.8%€594k▲ 12.4%€511k▼ 14.0%€504k▼ 1.3%
Operating result€37k-€54k▲ 44.0%€87k▲ 62.2%€-64k€30k
Net result€30k-€38k▲ 27.8%€66k▲ 72.2%€-83k€16k
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2026: €30k after a loss of €64k in 2025.
Balance-sheet composition
2026 in colour, 2025 as the grey bar beneath
Assets €670k
Fixed assets
€106k ▲ 0.9%
Current assets
€564k ▲ 4.6%
Equity and liabilities €670k
Equity
€504k ▼ 1.3%
Debt
€165k ▲ 24.2%
Debt's share of the balance-sheet total rises from 20.7% to 24.7%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€34k▲
2025 · €-47k
Cash flow
€20k▲
2025 · €-65k
Current ratio
3.45▼
2025 · 4.05
Quick ratio
2.33▼
2025 · 2.63
Debt to equity
0.33▲
2025 · 0.26
ROE
3.1%▲
2025 · -16.3%
ROA
2.3%▲
2025 · -12.9%
Interest coverage
4.29▲
2025 · -5.68
Debt ≤ 1 year
€164k▲
2025 · €133k
Income taxes
€9k▼
2025 · €13k
Staff costs
€134k▲
2025 · €132k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2026 against 2025 · 55 lines
Balance sheet
Code20252026
Assets
Total assets20/58€644k€670k▲
Fixed assets21/28€105k€106k▲
Tangible fixed assets22/27€105k€106k▲
Land and buildings22€100k€98k▼
Plant, machinery and equipment23€4k€2k▼
Furniture and vehicles24€2k€6k▲
Financial fixed assets28€194€194=
Current assets29/58€539k€564k▲
Stocks and contracts in progress3€189k€183k▼
Stocks30/36€189k€183k▼
Amounts receivable within one year40/41€82k€111k▲
Trade receivables40€60k€90k▲
Other amounts receivable41€22k€20k▼
Current investments50/53€55k€38k▼
Cash at bank and in hand54/58€208k€224k▲
Deferred charges and accrued income490/1€5k€9k▲
Equity and liabilities
Total equity and liabilities10/49€644k€670k▲
Equity10/15€511k€504k▼
Contributions10/11€20k€20k=
Reserves13€80k€59k▼
Non-distributable reserves130/1€38k€38k=
Reserves not available under the articles1311€38k€38k=
Tax-exempt reserves132€3k€3k=
Distributable reserves133€39k€18k▼
Profit (loss) carried forward14€410k€426k▲
Amounts payable17/49€133k€165k▲
Amounts payable within one year42/48€133k€164k▲
Trade debts44€71k€92k▲
Suppliers440/4€71k€92k▲
Taxes, remuneration and social security45€24k€36k▲
Taxes450/3€1k€11k▲
Remuneration and social security454/9€22k€25k▲
Other amounts payable47/48€38k€36k▼
Accrued charges and deferred income492/3-€2k
Income statement
Code20252026
Remuneration, social security and pensions62€132k€134k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€18k€4k▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€7k€7k▼
Other operating charges640/8€1k€1k▼
Non-recurring operating charges66A€111k-
Gross operating margin9900€205k€176k▼
Operating profit (loss)9901€-64k€30k▲
Financial income75/76B€2k€3k▲
Recurring financial income75€2k€3k▲
Financial charges65/66B€8k€8k▼
Recurring financial charges65€8k€8k▼
Profit (loss) for the period before taxes9903€-70k€24k▲
Income taxes67/77€13k€9k▼
Profit (loss) for the period9904€-83k€16k▲
Profit (loss) for the period to be appropriated9905€-83k€16k▲
Appropriation of the result
Profit (loss) to be appropriated9906€410k€426k▲
Profit (loss) brought forward from the previous period14P€494k€410k▼
Transfer from equity791/2-€22k
Profit to be distributed694/7-€22k
Return on contributions (dividend)694-€22k
Social balance
Average headcount (FTE)90871.41.4=
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2027, expected by
2026
03-06
NBB filing
Annual accounts filed
fiscal year 2026 · abbreviated schema
31-01
Financial
Back to profitnet €16k
Net result €16k after one loss-making year.
2025
22-09
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 22 days late
31-01
Financial
Weakest financial yearnet €-83k ▼226%
Net result drops to €-83k, the lowest in the series; recovery starts the following year.
2024
25-09
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 25 days late
31-01
Financial
Highest result since 2019net €66k ▲72.2%
Operating result €87k, net result €66k, both a record.
2023
29-09
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 29 days late
31-01
Financial
Equity above €500kEq €528k ▲7.8%
5 profitable years in a row build equity to €528k.
2022
22-09
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 22 days late
2021
28-09
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 28 days late
2020
30-10
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 60 days late
2019
16-09
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 16 days late
2018
27-09
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 27 days late
2017
29-09
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, De Panne · 1 establishment unit since 1965
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Zeelaan 1268660 De PanneGround area
202 m²
Building footprint
202 m²
Volume, LiDAR
2,149 m³
Parcel 38008A0019/00A000, Flanders · tallest building 25.9 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Zeelaan 126A, 8660 De Panne
since 19652.000.341.918
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 38008A0019/00A000 | Flanders | 202 m² | 1 · 202 m² | 25.9 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2023 · 1 entry · 2,000 EUR awarded · 2,000 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2023 | 1 | 2,000 EUR | 2,000 EUR |
Schemes
Hinderpremie bij openbare werken
Recognitions · licences · registrations
Legal Entity Identifier
967600KL9G6MP9WRVI20
Similar companies · same sector, comparable size
APOTHEEK GLIBERT-LOX
BE 0829.917.251
Ronse · Eq €504,639
PHARMACIE GUILMIN - LAMBEAU
BE 0430.195.691
Wavre · Eq €504,301
APOTHEEK VANACHTER
BE 0425.070.133
Puurs-Sint-Amands · Eq €504,693
BENEPHARMA
BE 0685.992.809
Overijse · Eq €504,818
APOTHEEK BAETENS
BE 0429.339.123
Evergem · Eq €504,092
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,357 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded01-01-1968
Fiscal year end31-01
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
47750Retail sale of cosmetics and toilet articles
Sources
Crossroads Bank for EnterprisesNational Bank · 49 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.